ArticleCell reports2025

Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling.

Hao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.